诚达药业：深圳前海晟泰投资企业(有限合伙)拟减持不超7.27%股份

Core Viewpoint - Chengda Pharmaceutical (301201) announced that its shareholder Shenzhen Qianhai Shengtai Investment Enterprise (Limited Partnership) plans to reduce its holdings of 11.0069 million shares, representing 7.27% of the company's total share capital after excluding repurchased shares, within three months from September 29, 2025, to December 28, 2025, through centralized bidding or block trading [1] Summary by Relevant Sections - Shareholder Reduction Plan - Shenzhen Qianhai Shengtai Investment Enterprise intends to reduce its stake by up to 11.0069 million shares [1] - This reduction accounts for 7.27% of the company's total share capital after excluding repurchased shares [1] - The planned reduction period is from September 29, 2025, to December 28, 2025 [1] - Trading Method - The shares will be sold through centralized bidding or block trading methods [1]